Clinical Trials Directory

Trials / Completed

CompletedNCT07064187

Evaluate The Improvement In Symptoms Of Patients Using Cationorm After Pterygium Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Nguyen Viet Giap · Academic / Other
Sex
All
Age
35 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The goal of this interventional clinical trial is to learn whether Cationorm can improve symptoms after pterygium surgery. The main question it aims to answer is what is the level of improvement of symptoms after pterygium surgery. Researchers will compare with other artificial tears (hyaluronic acid, polymers or cellulose derivatives eye drops) arm to see if Cationorm is similar or superior in terms of improvement of symptoms after pterygium surgery. Participants will * Take 1 drop Cationorm/artificial tear before and after surgery and during follow up. * Visit for checkups after 7 days

Detailed description

Participants will take: * Before surgery: 1 drop Cationorm/artificial tear at the eye that will undergo surgery * After surgery: 1 drop Cationorm/artificial tear at the eye that underwent surgery before eye bandages * Follow up after surgery: 1 drop Cationorm/artificial tear 4-6 times/day alternating with antibiotics (third-fourth generation quinolone) with 2-hour interval between drops * Maintenance phase: 7-14 days with the same regimen * After day 5, if fluorescein staining (-), can add corticosteroid monotherapy or addition with antibiotics * After 5 days of surgery, can add more antibiotics depend on the symptoms of patients

Conditions

Interventions

TypeNameDescription
DRUGCationorm single-dose eye dropCationorm single-dose eye drop is a preservative-free, cationic oil-in-water nano-emulsion.
DRUGArtificial tear eye dropArtificial tear eye drops are hyaluronic acid, polymers or cellulose derivatives eye drops

Timeline

Start date
2022-06-15
Primary completion
2022-08-15
Completion
2022-08-15
First posted
2025-07-14
Last updated
2025-08-06

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT07064187. Inclusion in this directory is not an endorsement.